Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Rezolute (NASDAQ:RZLT)

Core Points - Rezolute, Inc. has granted equity inducement awards to two new employees as of October 31, 2025, to encourage their acceptance of employment [1] - The company granted options to purchase a total of 245,000 shares of common stock at an exercise price of $9.32, which is the closing price on the grant date [2] Summary by Sections Company Overview - Rezolute, Inc. is a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism [1] Employee Inducement - The equity awards were approved by the Compensation Committee of the Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4) [1] - The options have a 10-year term and vest over four years, contingent on the employees' continued service [2] Stock Options Details - The options granted allow the purchase of 245,000 shares of Rezolute common stock at an exercise price of $9.32 [2]